-
1
-
-
0015230817
-
Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis
-
Yam LT, Li CY, Lam KW. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med. 1971;284(7):357-360.
-
(1971)
N Engl J Med
, vol.284
, Issue.7
, pp. 357-360
-
-
Yam, L.T.1
Li, C.Y.2
Lam, K.W.3
-
2
-
-
79959293462
-
BRAF mutations in hairy-cell leukemia
-
Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305-2315.
-
(2011)
N Engl J Med
, vol.364
, Issue.24
, pp. 2305-2315
-
-
Tiacci, E.1
Trifonov, V.2
Schiavoni, G.3
-
3
-
-
79959795786
-
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
-
Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507-2516.
-
(2011)
N Engl J Med
, vol.364
, Issue.26
, pp. 2507-2516
-
-
Chapman, P.B.1
Hauschild, A.2
Robert, C.3
-
4
-
-
77950398474
-
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine
-
Sigal DS, Sharpe R, Burian C, Saven A. Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood. 2010;115(10):1893-1896.
-
(2010)
Blood
, vol.115
, Issue.10
, pp. 1893-1896
-
-
Sigal, D.S.1
Sharpe, R.2
Burian, C.3
Saven, A.4
-
5
-
-
0020693431
-
Response to splenectomy in 65 patients with hairy cell leukemia: An evaluation of spleen weight and bone marrow involvement
-
Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983;61(2):349-352. (Pubitemid 13137656)
-
(1983)
Blood
, vol.61
, Issue.2
, pp. 349-352
-
-
Golomb, H.M.1
Vardiman, J.W.2
-
6
-
-
0022217573
-
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients
-
DOI 10.1002/1097-0142(19851201)56:11<2557::AID-CNCR2820561103>3.0. CO;2-T
-
Magee MJ, McKenzie S, Filippa DA, Arlin ZA, Gee TS, Clarkson BD. Hairy cell leukemia: durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Cancer. 1985;56(11):2557-2562. (Pubitemid 16249913)
-
(1985)
Cancer
, vol.56
, Issue.11
, pp. 2557-2562
-
-
Magee, M.J.1
McKenzie, S.2
Filippa, D.A.3
-
7
-
-
0021345092
-
Alpha interferon for induction of remission in hairy-cell leukemia
-
Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med. 1984;310(1):15-18. (Pubitemid 14212475)
-
(1984)
New England Journal of Medicine
, vol.310
, Issue.1
, pp. 15-18
-
-
Quesada, J.R.1
Reuben, J.2
Manning, J.T.3
-
8
-
-
0022525650
-
Treatment of hairy cell leukemia with recombinant alpha-interferon
-
Quesada JR, Hersh EM, Manning J, et al. Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood. 1986;68(2):493-497. (Pubitemid 16050674)
-
(1986)
Blood
, vol.68
, Issue.2
, pp. 493-497
-
-
Quesada, J.R.1
Hersh, E.M.2
Manning, J.3
-
9
-
-
0028929938
-
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An Intergroup study
-
Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an Intergroup study. J Clin Oncol. 1995;13(4):974-982.
-
(1995)
J Clin Oncol
, vol.13
, Issue.4
, pp. 974-982
-
-
Grever, M.1
Kopecky, K.2
Foucar, M.K.3
-
10
-
-
0021681936
-
Hairy-cell leukemia: Induction of complete remission with pentostatin (2'-deoxycoformycin)
-
Spiers AS, Parekh SJ, Bishop MB. Hairy-cell leukemia: induction of complete remission with pentostatin (2′-deoxycoformycin). J Clin Oncol. 1984;2(12):1336-1342. (Pubitemid 15179534)
-
(1984)
Journal of Clinical Oncology
, vol.2
, Issue.12
, pp. 1336-1342
-
-
Spiers, A.S.D.1
Parekh, S.J.2
Bishop, M.B.3
-
12
-
-
0025274664
-
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine
-
Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med. 1990;322(16):1117-1121. (Pubitemid 20149529)
-
(1990)
New England Journal of Medicine
, vol.322
, Issue.16
, pp. 1117-1121
-
-
Piro, L.D.1
Carrera, C.J.2
Carson, D.A.3
Beutler, E.4
-
13
-
-
0032530684
-
Long-term follow-up of patients with hairy cell leukemia after cladribine treatment
-
Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood. 1998;92(6):1918- 1926. (Pubitemid 28446680)
-
(1998)
Blood
, vol.92
, Issue.6
, pp. 1918-1926
-
-
Saven, A.1
Burian, C.2
Koziol, J.A.3
Piro, L.D.4
-
14
-
-
0037362951
-
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine
-
DOI 10.1200/JCO.2003.05.093
-
Goodman GR, Burian C, Koziol JA, Saven A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol. 2003;21(5):891-896. (Pubitemid 46606450)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.5
, pp. 891-896
-
-
Goodman, G.R.1
Burian, C.2
Koziol, J.A.3
Saven, A.4
-
15
-
-
22044444135
-
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): Long-term follow-up of the Northwestern University experience
-
DOI 10.1182/blood-2005-01-0173
-
Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106(1):241-246. (Pubitemid 40967199)
-
(2005)
Blood
, vol.106
, Issue.1
, pp. 241-246
-
-
Chadha, P.1
Rademaker, A.W.2
Mendiratta, P.3
Kim, B.4
Evanchuk, D.M.5
Hakimian, D.6
Peterson, L.C.7
Tallman, M.S.8
-
16
-
-
4444288930
-
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine
-
DOI 10.1038/sj.leu.2403418
-
Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia. 2004;18(9):1476-1481. (Pubitemid 39264069)
-
(2004)
Leukemia
, vol.18
, Issue.9
, pp. 1476-1481
-
-
Jehn, U.W.1
Bartl, R.2
Dietzfelbinger, H.3
Haferlach, T.4
Heinemann, V.5
-
17
-
-
0028925970
-
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia
-
Juliusson G, Heldal D, Hippe E, et al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol. 1995;13(4):989-995.
-
(1995)
J Clin Oncol
, vol.13
, Issue.4
, pp. 989-995
-
-
Juliusson, G.1
Heldal, D.2
Hippe, E.3
-
18
-
-
0036809024
-
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: A phase II study
-
DOI 10.1093/annonc/mdf272
-
von Rohr A, Schmitz SF, Tichelli A, et al. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Ann Oncol. 2002;13(10):1641-1649. (Pubitemid 35331464)
-
(2002)
Annals of Oncology
, vol.13
, Issue.10
, pp. 1641-1649
-
-
Von, R.A.1
Schmitz, S.-F.H.2
Tichelli, A.3
Hess, U.4
Piguet, D.5
Wernli, M.6
Frickhofen, N.7
Konwalinka, G.8
Zulian, G.9
Ghielmini, M.10
Rufener, B.11
Racine, C.12
Fey, M.F.13
Cerny, T.14
Betticher, D.15
Tobler, A.16
-
19
-
-
0031016704
-
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy- cell leukemia: A new treatment schedule effective and safer in preventing infectious complications [5]
-
Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Blood. 1997;89(5):1838-1839. (Pubitemid 27097485)
-
(1997)
Blood
, vol.89
, Issue.5
, pp. 1838-1839
-
-
Lauria, F.1
Bocchia, M.2
Marotta, G.3
Raspadori, D.4
Zinzani, P.5
Rondelli, D.6
-
20
-
-
0032858782
-
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy- cell leukemia is effective and reduces infectious complications
-
Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Haematologica. 1999;84(1):22-25. (Pubitemid 29479379)
-
(1999)
Haematologica
, vol.84
, Issue.1
, pp. 22-25
-
-
Lauria, F.1
Bocchia, M.2
Marotta, G.3
Raspadori, D.4
Zinzani, P.L.5
Rondelli, D.6
-
21
-
-
2942738755
-
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
-
Zinzani PL, Tani M, Marchi E, et al. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Haematologica. 2004;89(3):309-313. (Pubitemid 38788415)
-
(2004)
Haematologica
, vol.89
, Issue.3
, pp. 309-313
-
-
Zinzani, P.L.1
Tani, M.2
Marchi, E.3
Stefoni, V.4
Alinari, L.5
Musuraca, G.6
Gabriele, A.7
Pileri, S.8
Baccarani, M.9
-
22
-
-
34247339681
-
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: Final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial
-
DOI 10.1182/blood-2006-08-042929
-
Robak T, Jamroziak K, Gora-Tybor J, et al. Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial. Blood. 2007;109(9):3672-3675. (Pubitemid 46641714)
-
(2007)
Blood
, vol.109
, Issue.9
, pp. 3672-3675
-
-
Robak, T.1
Jamroziak, K.2
Gora-Tybor, J.3
Blonski, J.Z.4
Kasznicki, M.5
Dwilewicz-Trojaczek, J.6
Wiater, E.7
Zdunczyk, A.8
Dybowicz, J.9
Dmoszynska, A.10
Wojtaszko, M.11
Zdziarska, B.12
Calbecka, M.13
Kostyra, A.14
Hellmann, A.15
Lewandowski, K.16
Stella-Holowiecka, B.17
Sulek, K.18
Gawronski, K.19
Skotnicki, A.B.20
Nowak, W.21
Zawilska, K.22
Molendowicz-Portala, L.23
Kloczko, J.24
Sokolowski, J.25
Warzocha, K.26
Seferynska, I.27
Ceglarek, B.28
Konopka, L.29
more..
-
23
-
-
77950396626
-
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: A multicenter phase III trial (SAKK 32/98)
-
Zenhausern R, Schmitz SF, Solenthaler M, et al. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leuk Lymphoma. 2009;50(9):1501-1511.
-
(2009)
Leuk Lymphoma
, vol.50
, Issue.9
, pp. 1501-1511
-
-
Zenhausern, R.1
Schmitz, S.F.2
Solenthaler, M.3
-
24
-
-
85047332993
-
Analysis of toxicity and efficacy of subcutaneous cladribine at reduced or standard doses (five versus seven consecutive days) in patients with hairy cell leukemia (HCL) in the ICGHCL2004 Protocol by the Italian Cooperative Group on HCL
-
ASH abstract 701
-
Forconi F, Cencini E, Zaja F, et al. Analysis of toxicity and efficacy of subcutaneous cladribine at reduced or standard doses (five versus seven consecutive days) in patients with hairy cell leukemia (HCL) in the ICGHCL2004 Protocol by the Italian Cooperative Group on HCL [ASH abstract 701]. Blood. 2010;116.
-
(2010)
Blood
, pp. 116
-
-
Forconi, F.1
Cencini, E.2
Zaja, F.3
-
25
-
-
0026799508
-
Cladribine (2-chlorodeoxyadenosine)
-
Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet. 1992;340(8825):952-956.
-
(1992)
Lancet
, vol.340
, Issue.8825
, pp. 952-956
-
-
Beutler, E.1
-
26
-
-
0027941692
-
Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin
-
Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood. 1994;84(12):4061-4063.
-
(1994)
Blood
, vol.84
, Issue.12
, pp. 4061-4063
-
-
Kraut, E.H.1
Grever, M.R.2
Bouroncle, B.A.3
-
27
-
-
0032940595
-
Long term outcome of patients with hairy cell leukemia treated with pentostatin
-
DOI 10.1002/(SICI)1097-0142(19990101)85:1<65::AID-CNCR9>3.0.CO;2-B
-
Ribeiro P, Bouaffia F, Peaud PY, et al. Long term outcome of patients with hairy cell leukemia treated with pentostatin. Cancer. 1999;85(1):65-71. (Pubitemid 29031357)
-
(1999)
Cancer
, vol.85
, Issue.1
, pp. 65-71
-
-
Ribeiro, P.1
Bouaffia, F.2
Peaud, P.-Y.3
Blanc, M.4
Salles, B.5
Salles, G.6
Coiffier, B.7
-
28
-
-
0034329819
-
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
-
Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000;96(9):2981-2986.
-
(2000)
Blood
, vol.96
, Issue.9
, pp. 2981-2986
-
-
Flinn, I.W.1
Kopecky, K.J.2
Foucar, M.K.3
-
29
-
-
0037269178
-
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients
-
DOI 10.1038/sj.leu.2402784
-
Maloisel F, Benboubker L, Gardembas M, et al. Long-term outcome with pentostatin treatment in hairy cell leukemia patients: a French retrospective study of 238 patients. Leukemia. 2003;17(1):45-51. (Pubitemid 36175887)
-
(2003)
Leukemia
, vol.17
, Issue.1
, pp. 45-51
-
-
Maloisel, F.1
Benboubker, L.2
Gardembas, M.3
Coiffier, B.4
Divine, M.5
Sebban, C.6
Blanc, M.7
Abgrall, J.-F.8
Lederlin, P.9
Harousseau, J.-L.10
Blaise, A.-M.11
Grosbois, B.12
Morice, P.13
Ghandour, C.14
Castaigne, S.15
-
30
-
-
0032842507
-
Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine
-
DOI 10.1046/j.1365-2141.1999.01546.x
-
Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. Br J Haematol. 1999;106(2):515-519. (Pubitemid 29450680)
-
(1999)
British Journal of Haematology
, vol.106
, Issue.2
, pp. 515-519
-
-
Dearden, C.E.1
Matutes, E.2
Hilditch, B.L.3
Swansbury, G.J.4
Catovsky, D.5
-
31
-
-
66749169284
-
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
-
Else M, Dearden CE, Matutes E, et al. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol. 2009;145(6):733-740.
-
(2009)
Br J Haematol
, vol.145
, Issue.6
, pp. 733-740
-
-
Else, M.1
Dearden, C.E.2
Matutes, E.3
-
32
-
-
0042243678
-
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia
-
DOI 10.1182/blood-2003-01-0014
-
Nieva J, Bethel K, Saven A. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood. 2003;102(3):810-813. (Pubitemid 36917768)
-
(2003)
Blood
, vol.102
, Issue.3
, pp. 810-813
-
-
Nieva, J.1
Bethel, K.2
Saven, A.3
-
33
-
-
0035669026
-
Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
-
DOI 10.1046/j.1365-2141.2001.03143.x
-
Hagberg H, Lundholm L. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol. 2001;115(3):609-611. (Pubitemid 34015651)
-
(2001)
British Journal of Haematology
, vol.115
, Issue.3
, pp. 609-611
-
-
Hagberg, H.1
Lundholm, L.2
-
34
-
-
50849088318
-
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)
-
Zenhausern R, Simcock M, Gratwohl A, Hess U, Bargetzi M, Tobler A. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica. 2008;93(9):1426-1428.
-
(2008)
Haematologica
, vol.93
, Issue.9
, pp. 1426-1428
-
-
Zenhausern, R.1
Simcock, M.2
Gratwohl, A.3
Hess, U.4
Bargetzi, M.5
Tobler, A.6
-
35
-
-
0345689335
-
Rituximab in relapsed or refractory hairy cell leukemia
-
DOI 10.1182/blood-2003-02-0630
-
Thomas DA, O'Brien S, Bueso-Ramos C, et al. Rituximab in relapsed or refractory hairy cell leukemia. Blood. 2003;102(12):3906-3911. (Pubitemid 37486969)
-
(2003)
Blood
, vol.102
, Issue.12
, pp. 3906-3911
-
-
Thomas, D.A.1
O'Brien, S.2
Bueso-Ramos, C.3
Faderl, S.4
Keating, M.J.5
Giles, F.J.6
Cortes, J.7
Kantarjian, H.M.8
-
36
-
-
33745075957
-
Eradication of minimal residual disease in hairy cell leukemia
-
DOI 10.1182/blood-2005-11-4590
-
Ravandi F, Jorgensen JL, O'Brien SM, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood. 2006;107(12):4658-4662. (Pubitemid 43882611)
-
(2006)
Blood
, vol.107
, Issue.12
, pp. 4658-4662
-
-
Ravandi, F.1
Jorgensen, J.L.2
O'Brien, S.M.3
Verstovsek, S.4
Koller, C.A.5
Faderl, S.6
Giles, F.J.7
Ferrajoli, A.8
Wierda, W.G.9
Odinga, S.10
Huang, X.11
Thomas, D.A.12
Freireich, E.J.13
Jones, D.14
Keating, M.J.15
Kantarjian, H.M.16
-
37
-
-
79961229946
-
Phase II study of sequential therapy with cladribine followed by an extended course rituximab in patients with hairy cell leukemia
-
ASH abstract 2458
-
Ravandi F, Jorgensen J, O'Brien S, et al. Phase II study of sequential therapy with cladribine followed by an extended course rituximab in patients with hairy cell leukemia [ASH abstract 2458]. Blood. 2010;116.
-
(2010)
Blood
, pp. 116
-
-
Ravandi, F.1
Jorgensen, J.2
O'Brien, S.3
-
38
-
-
52649089106
-
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: Extended follow-up
-
Cervetti G, Galimberti S, Andreazzoli F, et al. Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up. Br J Haematol. 2008;143(2):296-298.
-
(2008)
Br J Haematol
, vol.143
, Issue.2
, pp. 296-298
-
-
Cervetti, G.1
Galimberti, S.2
Andreazzoli, F.3
-
39
-
-
79957474897
-
Rituximab with pentostatin or cladribine: An effective combination treatment for hairy cell leukemia after disease recurrence
-
Else M, Dearden CE, Matutes E, et al. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leuk Lymphoma. 2011;52(suppl 2):75-78.
-
(2011)
Leuk Lymphoma
, vol.52
, Issue.SUPPL. 2
, pp. 75-78
-
-
Else, M.1
Dearden, C.E.2
Matutes, E.3
-
40
-
-
0033561067
-
Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia
-
Saven A, Burian C, Adusumalli J, Koziol JA. Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia. Blood. 1999;93(8):2471-2477. (Pubitemid 29181177)
-
(1999)
Blood
, vol.93
, Issue.8
, pp. 2471-2477
-
-
Saven, A.1
Burian, C.2
Adusumalli, J.3
Koziol, J.A.4
-
41
-
-
0035954624
-
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia
-
DOI 10.1056/NEJM200107263450402
-
Kreitman RJ, Wilson WH, Bergeron K, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med. 2001;345(4):241-247. (Pubitemid 32695063)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.4
, pp. 241-247
-
-
Kreitman, R.J.1
Wilson, W.H.2
Bergeron, K.3
Raggio, M.4
Stetler-Stevenson, M.5
Fitzgerald, D.J.6
Pastan, I.7
-
42
-
-
67649933809
-
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia
-
Kreitman RJ, Stetler-Stevenson M, Margulies I, et al. Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol. 2009;27(18):2983-2990.
-
(2009)
J Clin Oncol
, vol.27
, Issue.18
, pp. 2983-2990
-
-
Kreitman, R.J.1
Stetler-Stevenson, M.2
Margulies, I.3
-
43
-
-
80051743261
-
A phase 1 study of moxetumomab pasudotox, an anti-CD22 recombinant immunotoxin, in relapsed/refractory hairy cell leukemia (HCL): Updated results
-
ASH abstract 2516
-
Kreitman RJ, Tallman MS, Coutre S, et al. A phase 1 study of moxetumomab pasudotox, an anti-CD22 recombinant immunotoxin, in relapsed/refractory hairy cell leukemia (HCL): updated results [ASH abstract 2516]. Blood. 2010;116.
-
(2010)
Blood
, pp. 116
-
-
Kreitman, R.J.1
Tallman, M.S.2
Coutre, S.3
-
44
-
-
5444223561
-
Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment [1]
-
DOI 10.1038/sj.thj.6200373
-
Fietz T, Rieger K, Schmittel A, Thiel E, Knauf W. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment. Hematol J. 2004;5(5):451-452. (Pubitemid 39359285)
-
(2004)
Hematology Journal
, vol.5
, Issue.5
, pp. 451-452
-
-
Fietz, T.1
Rieger, K.2
Schmittel, A.3
Thiel, E.4
Knauf, W.5
-
45
-
-
79957508822
-
Response of hairy cell leukemia to bendamustine
-
Kreitman RJ, Arons E, Stetler-Stevenson M, Miller KB. Response of hairy cell leukemia to bendamustine. Leuk Lymphoma. 2011;52(6):1153-1156.
-
(2011)
Leuk Lymphoma
, vol.52
, Issue.6
, pp. 1153-1156
-
-
Kreitman, R.J.1
Arons, E.2
Stetler-Stevenson, M.3
Miller, K.B.4
|